NB. This article is not published yet. Please try again later.
More Popular Related Articles on Food, Drugs, Healthcare, Life Sciences from Asia Pacific
Corrs Chambers Westgarth
The Australian aged care sector is experiencing a period of rapid change, with five emerging trends as a key 2015 focus.
ZEUS Law Associates
In its Cabinet Note in December, 2014, the Government of India proposed significant amendments to the Consolidated Foreign Direct Investment Policy, 2014 (''FDI Policy'') with respect to India's medical device industry.
Ropes & Gray LLP
The CFDA expects all device companies to comply with the New GMP and GSP rules as long as they intend to sell the products in China.
King & Wood Mallesons
This series of regulatory actions demonstrate efforts to strengthen the administration of medical devices and equipment.
Vaish Associates Advocates
The food processing industry one of the largest industries in India is widely recognized as a 'sunrise industry' in India having huge potential for uplifting the agricultural economy, creation of large scale processed food manufacturing and food chain facilities, and the resultant generation of employment and export earnings.
Singh & Associates
Indian Pharmaceutical Industry is at present, at its most progressive era where it has witnessed a robust growth over the past few years.
Nishith Desai Associates
April 6, 2014 was a red letter day for the Indian pharmaceutical industry as Sun Pharmaceutical Industries Limited ("Sun Pharma") and Ranbaxy Laboratories Limited ("Ranbaxy") announced that they had entered into definitive documents for merger of Ranbaxy with Sun Pharma ("Transaction").
A material amendment to the law regulating drugs and medical devices in Japan has recently been implemented.